LABORATORIOS FARMACEUTICOS ROVI, S.A. «...1112131415...» Page 12 out of 18 07/02/2022 13:18 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022 Register number: 13969 31/01/2022 12:51 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 24 January 2021 and 28 January 2021 Register number: 13804 24/01/2022 11:43 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 17 January 2021 and 21 January 2021 Register number: 13718 17/01/2022 12:52 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 10 January 2021 and 14 January 2021 Register number: 13628 10/01/2022 12:19 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 3 January 2021 and 7 January 2021 Register number: 13544 03/01/2022 17:14 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 27 December 2021 and 31 December 2021. Register number: 13457 28/12/2021 11:46 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 20 December 2021 and 24 December 2021. Register number: 13366 20/12/2021 12:48 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 13 December 2021 and 17 December 2021. Register number: 13283 17/12/2021 12:37 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company reports that the Committee for Medical Products for Human Use (CHMP) has issued a positive opinion on Okedi® (Risperidone ISM®) for the treatment for schizophrenia. Register number: 13249 13/12/2021 11:11 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 6 December 2021 and 10 December 2021. Register number: 13131 Page 12 out of 18 «...1112131415...»